OPEN END-TURBO-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 15:36:46 2024-06-24 EDT | ||
| 8.94 EUR | +6.43% |
|
| Current month | +14.03% | ||
| 1 month | +10.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-24 | 8.94 | +6.43% |
| 24-06-21 | 8.4 | +0.48% |
| 24-06-20 | 8.36 | +3.59% |
| 24-06-19 | 8.07 | +1.13% |
| 24-06-18 | 7.98 | +2.70% |
Real-time BOERSE MUENCHEN
Last update June 24, 2024 at 03:36 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | TT1SYB |
| ISIN | DE000TT1SYB3 |
| Date issued | 2020-04-06 |
| Strike | 220.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.34 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.29 € |
|---|---|
| Lowest since issue | 0.35 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
318.2
USD
Average target price
316.4
USD
Spread / Average Target
-0.54%
- Stock Market
- Certificates
- Certificat
